Previous Article | Next Article 
Journal of Clinical Microbiology, April 2003, p. 1775-1778, Vol. 41, No. 4
0095-1137/03/$08.00+0 DOI: 10.1128/JCM.41.4.1775-1778.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Distribution of the saa Gene in Strains of Shiga Toxin-Producing Escherichia coli of Human and Bovine Origins
Claire Jenkins,1,2* Neil T. Perry,1 Tom Cheasty,1 Darren J. Shaw,3 Gad Frankel,2 Gordon Dougan,2 George J. Gunn,4 Henry R. Smith,1 Adrienne W. Paton,5 and James C. Paton5
Laboratory of Enteric Pathogens, Central Public Health Laboratory, London NW9 5HT,1
Centre for Molecular Microbiology and Immunology, Imperial College, London SW7 2AZ,2
Centre for Tropical and Veterinary Medicine, University of Edinburgh, Roslin, Midlothian EH25 9RG,3
Scottish Agricultural College, Drummondhill, Inverness IV2 4JZ, United Kingdom,4
Department of Molecular Biosciences, University of Adelaide, Adelaide, South Australia 5005, Australia5
Received 8 November 2002/
Accepted 7 January 2003

ABSTRACT
Certain strains of Shiga toxin-producing
Escherichia coli (STEC)
which do not have the locus of enterocyte effacement pathogenicity
island carry the STEC autoagglutinating adhesin (
saa) gene.
The distribution of the
saa gene in STEC isolates from patients
with hemolytic-uremic syndrome (HUS), patients with less severe
diarrheal disease, asymptomatic individuals, and healthy cattle
was examined.
saa-positive strains were detected more frequently
(
P < 0.001) in STEC strains from bovines (32 of 56 strains)
than in those from humans (8 of 91 strains). No significant
association (
P = 0.135) was found between the
saa gene and STEC
isolated from patients with HUS (6 of 46 strains) or diarrhea
(2 of 29 strains) and from healthy controls (0 of 16 strains).

TEXT
Shiga toxin-producing
Escherichia coli (STEC), also referred
to as verocytotoxin-producing
E. coli, cause a broad spectrum
of disease in humans ranging from mild diarrhea to severe disease,
such as hemorrhagic colitis and hemolytic-uremic syndrome (HUS)
(
2,
8,
20). A wide range of STEC serogroups can cause human
disease, although the most commonly isolated serogroups from
patients infected with STEC, notably O26, O103, O111, O145,
and O157 (
16,
21), are those harboring the locus of enterocyte
effacement (LEE) (
4). One of the genes located on the LEE is
eae (
E. coli attaching and effacing), which encodes intimin,
an outer membrane protein involved in intimate attachment of
the bacteria to intestinal host cells (
4). However, the presence
of the LEE is not essential for pathogenesis, as a number of
cases of severe STEC disease, including HUS, have been caused
by LEE-negative strains (
6,
9,
12). Paton et al. recently described
a novel autoagglutinating adhesin, designated Saa (STEC autoagglutinating
adhesin), in a LEE-negative O113:H21 STEC strain responsible
for an outbreak of HUS (
13). Those authors presented evidence
that the
saa gene was plasmid encoded and associated with the
STEC enterohemolysin genes (
13,
14). The
saa gene was also detected
in certain other STEC isolates from humans, including other
LEE-negative strains isolated from sporadic HUS cases (
14).
This raised the possibility that Saa might be a virulence factor
for virulent LEE-negative STEC in humans, but there were insufficient
numbers of strains available for testing to draw any firm conclusions.
In the present study, we examined the distribution of the
saa gene in a large collection of STEC isolates from patients with
HUS and diarrheal disease and from a healthy control group to
test whether there is any association between the presence of
saa and severe human STEC disease. We also investigated the
distribution of the
saa gene in isolates from healthy cattle
in the United Kingdom to determine whether this gene may be
associated with bovine STEC.
The 91 strains of STEC from the culture collection of the Laboratory of Enteric Pathogens (LEP), London, United Kingdom, comprised 46 strains from patients with HUS (Table 1), 29 isolated from patients with diarrhea who did not develop HUS (Table 2), and 16 from a healthy control group (Table 3) (3, 8, 16, 18, 19). Sixty-one of these strains were differentiated by serotyping, stx typing, and the presence or absence of the eae and STEC enterohemolysin (ehxA) genes (5, 11, 15, 17). The strains were isolated between 1983 and 2000 either at the LEP from fecal samples submitted for detection of STEC or at hospital laboratories and then sent to the LEP for confirmation and further tests. Fecal pat samples collected from healthy cattle from 41 different farms in Scotland between 1996 and 1999 were examined for the presence of STEC strains other than those belonging to serogroup O157 (7). Fifty-six STEC strains were isolated from 423 fecal samples; 30 of these strains were differentiated by serotyping, stx typing, and the presence or absence of the eae and ehxA genes (5, 11, 15, 17) (Table 4). These strains were tested for the presence of saa by PCR with primers 5'-CGTGATGAACAGGCTATTGC and 5'-ATGGACATGCCTGTGGCAAC, which amplify a 119-bp portion of the saa gene (14). To test for differences in the detection of particular genes between the four groups of strains, generalized linear models with binomial errors were performed. In all cases, a P value of <0.05 was taken to indicate significance. Fisher's exact tests were performed to test the significance of the association between the detection of particular genes.
View this table:
[in this window]
[in a new window]
|
TABLE 2. Characterization of non-O157 STEC strains isolated from patients with diarrhea but who did not develop HUSa
|
View this table:
[in this window]
[in a new window]
|
TABLE 3. Strains of non-O157 STEC isolated from a healthy control group during a study of infectious intestinal diseasea
|
Forty (27%) of the 147 STEC strains in this study had the
saa gene (Tables
1-
3). None of these 40
saa-positive strains carried
the
eae gene, and 39 were
ehxA positive; the exceptional strain
(
saa positive and
ehxA negative) belonged to serotype O128ab:H8
(Table
2). The
saa gene was detected in 6 (13%) of 46 strains
from humans with HUS, and 28 (61%) of these 46 strains carried
the
eae gene, while 12 (26%) had neither (Table
1). Two (7%)
of 29 strains from patients with diarrhea or bloody diarrhea
who did not develop HUS were
saa positive. The
eae gene was
detected in 10 (34%) strains from this group, and 17 (59%) had
neither the
eae nor the
saa gene (Table
2). None of the isolates
from the healthy control group had the
saa gene (Table
3). Characterization
of the 56 bovine strains showed that 32 (57%) carried the
saa gene, 2 (4%) were
eae positive, and 22 (39%) were negative for
both
eae and
saa (Table
4). None of the strains harboring the
saa gene had the
eae gene.
Statistical analysis revealed a significant difference in the frequencies of saa-positive strains between the four groups (
2 = 45.45; df = 3; P < 0.001). However, if the cattle strains are excluded from the analysis, then this significance was lost (
2 = 4.00; df = 2; P = 0.135). Therefore, the number of cattle strains containing the saa gene is significantly higher than the number of saa-positive human strains, although there is no difference in the presence of the saa gene between the strains from patients with HUS, patients with diarrhea, and the asymptomatic individuals. Statistical tests also showed a significant difference in the frequencies of isolates containing the eae gene between the four groups (
2 = 55.89; df = 3; P < 0.001), with the highest frequency of intimin-positive strains being found in the HUS group.
Variables over and above the group categories (HUS, diarrhea, healthy control, and cattle strains), such as toxin type and the presence of the eae and ehxA genes, and the fact that certain serotypes are represented by more strains than are others may influence the results. However, the panel of strains reflects the fact that some serotypes associated with HUS (e.g., O26:H11) or less severe diarrhea (e.g., O128ab:H2) are more commonly isolated than others (2, 9, 16, 20, 21). To date, the saa gene has not been found in STEC strains harboring the eae gene, and the association of saa with bovine strains may be due to the fact that there are so few intimin-positive strains in this group. However, statistical analysis of only the intimin-negative strains showed that there was still a significantly higher frequency of saa-positive strains in STEC strains from cattle than in those from humans (P < 0.001, Fisher's exact test). Thirty-nine of 40 (98%) saa-positive strains also carried the ehxA genes, and 39 of 51 (76%) strains that were negative for the saa and eae genes were also negative for the ehxA gene. Tests showed that for the eae-negative strains, there was a significant association between the presence of the saa and ehxA genes (P < 0.001, Fisher's exact test). These results are consistent with the observation of Paton et al. that the saa gene is plasmid encoded and associated with the plasmid-encoded ehxA gene (13). Only one strain of serotype O128ab:H8 was saa positive but ehxA negative, and further work is being carried out to determine whether the saa gene is plasmid encoded in this strain.
The only saa-positive serotype common to both human and bovine STEC strains in this study was O105ac:H18. Carriage of the saa gene appeared to be specific to certain serotypes within a serogroup, e.g., O113:H21 was saa positive, whereas O113:H4 was saa negative. Of the 22 bovine serotypes that have yet to be designated as a formal "O" type (i.e., provisional types and "O?"), 13 carried the saa gene. This highlights the need to extend the serotyping scheme to include new and emerging STEC serogroups.
Our results showed that there was no significant association between strains of STEC isolated from patients with HUS and the saa gene, although they do support the suggestion that the eae gene is detected more frequently in STEC from this group of patients (1, 10). However, the saa gene was significantly associated with bovine STEC strains, suggesting that Saa may have a role in attachment to the bovine gut. Further work is being carried out, both in vitro and in vivo, to examine the role of Saa in attachment to the bovine gut mucosa.

ACKNOWLEDGMENTS
Fecal pat samples were collected as part of the study "Determination
of the Prevalence of
E. coli O157 in Scottish Beef Cattle" funded
by the Scottish Executive Environment and Rural Affairs Department.
Bovine STEC were isolated as part of the International Partnership
Research Award in Veterinary Epidemiology project entitled "Epidemiology
and Evolution of
Enterobacteriaceae Infections in Humans and
Domestic Animals" funded by the Wellcome Trust.
We thank Doreen Bassett, Jude Evans, Hazel Knight, Judi Lee, Alistair Smith, and Helen Ternent for their excellent technical assistance.

FOOTNOTES
* Corresponding author. Mailing address: Laboratory of Enteric Pathogens, Central Public Health Laboratory, 61 Colindale Ave., London NW9 5HT, United Kingdom. Phone: 44 020 8200 4400. Fax: 44 020 8905 9929. E-mail:
cjenkins{at}phls.org.uk.


REFERENCES
1 - Boerlin, P., S. A. McEwan, F. Boerlin-Petzold, J. B. Wilson, R. P. Johnson, and C. L. Gyles. 1999. Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J. Clin. Microbiol. 37:497-503.[Abstract/Free Full Text]
2 - Caprioli, A., A. E. Tozzi, G. Rizzoni, and H. Karch. 1997. Non-O157 Shiga toxin-producing Escherichia coli infections in Europe. Emerg. Infect. Dis. 3:578-579.[Medline]
3 - Evans, J., A. Wilson, G. A. Willshaw, T. Cheasty, D. S. Tompkins, J. G. Wheeler, and H. R. Smith. 2002. Vero cytotoxin-producing Escherichia coli in a study of infectious intestinal disease in England. Clin. Microbiol. Infect. Dis. 8:183-186.
4 - Frankel, G., A. Phillips, I. Rosenshine, G. Dougan, J. Kaper, and S. Knutton. 1998. Enteropathogenic and enterohaemorrhagic Escherichia coli: more subversive elements. Mol. Microbiol. 30:911-921.[CrossRef][Medline]
5 - Gross, R. J., and B. Rowe. 1985. Serotyping of Escherichia coli, p. 345-360. In M. Sussman (ed.) The virulence of Escherichia coli. Cambridge University Press, Cambridge, United Kingdom.
6 - Ito, H., A. Terai, H. Kurazono, Y. Takeda, and M. Nishibuchi. 1990. Cloning and nucleotide sequencing of Vero toxin 2 variant genes from Escherichia coli O91:H21 isolated from a patient with hemolytic uremic syndrome. Microb. Pathog. 8:47-60.[CrossRef][Medline]
7 - Jenkins, C., H. Chart, T. Cheasty, G. A. Willshaw, M. C. Pearce, G. Foster, G. J. Gunn, H. R. Smith, G. Dougan, B. A. Synge, and G. Frankel. 2002. Verocytotoxin-producing Escherichia coli (VTEC) other than serogroup O157 from Scottish cattle. Vet. Rec. 151:58-60.[Free Full Text]
8 - Karmali, M. 1989. Infection by verocytotoxin-producing Escherichia coli. Clin. Microbiol. Rev. 2:15-38.[Abstract/Free Full Text]
9 - Kleanthous, H., H. R. Smith, S. M. Scotland, R. J. Gross, B. Rowe, C. M. Taylor, and D. V. Milford. 1990. Haemolytic uraemic syndromes in the British Isles, 1985-1988: association with verocytotoxin producing Escherichia coli. Part 2. Microbiological aspects. Arch. Dis. Child. 65:722-727.[Abstract/Free Full Text]
10 - Meng, J., S. Zhao, and M. P. Doyle. 1998. Virulence genes of Shiga toxin-producing Escherichia coli isolated from food, animals and humans. Int. J. Food Microbiol. 45:229-235.[CrossRef][Medline]
11 - Oswald, E., H. Schmidt, S. Morabito, H. Karch, O. Marches, and A. Caprioli. 2000. Typing of intimin genes in human and animal enterohemorrhagic and enteropathogenic Escherichia coli: characterization of a new intimin variant. Infect. Immun. 68:64-71.[Abstract/Free Full Text]
12 - Paton, A. W., M. C. Woodrow, R. M. Doyle, J. A. Lanser, and J. C. Paton. 1999. Molecular characterization of a Shiga toxin Escherichia coli O113:H21 lacking eae responsible for a cluster of cases of hemolytic-uremic syndrome. J. Clin. Microbiol. 37:3357-3361.[Abstract/Free Full Text]
13 - Paton, A. W., P. Srimanote, M. C. Woodrow, and J. C. Paton. 2001. Characterization of Saa, a novel auto agglutinating adhesin produced by locus of enterocyte effacement-negative Shiga-toxigenic Escherichia coli strains that are virulent for humans. Infect. Immun. 69:6999-7009.[Abstract/Free Full Text]
14 - Paton, A. W., and J. C. Paton. 2002. Direct detection and characterization of Shiga toxigenic Escherichia coli by multiplex PCR for stx1, stx2, eae, ehxA, and saa. J. Clin. Microbiol. 40:271-274.[Abstract/Free Full Text]
15 - Schmidt, H., L. Beutin, and H. Karch. 1995. Molecular analysis of the plasmid-encoded haemolysin of Escherichia coli O157:H7 strain EDL 933. Infect. Immun. 63:1055-1060.[Abstract]
16 - Schmidt, H., C. Geitz, P. Tarr, M. Frosch, and H. Karch. 1999. Non-O157:H7 pathogenic Shiga toxin-producing Escherichia coli: phenotypic and genetic profiling of virulence traits and evidence of clonality. J. Infect. Dis. 179:115-123.[CrossRef][Medline]
17 - Thomas, A., H. R. Smith, G. A. Willshaw, and B. Rowe. 1991. Non-radioactively labelled polynucleotide and oligonucleotide DNA probes, for selectively detecting Escherichia coli strains producing Vero cytotoxins VT1, VT2 and VT2 variant. Mol. Cell. Probes 5:129-135.[CrossRef][Medline]
18 - Thomas, A., T. Cheasty, H. Chart, and B. Rowe. 1994. Isolation of Vero cytotoxin-producing Escherichia coli serotypes O9ab:H- and O101:H- carrying VT2 variant gene sequences from a patient with haemolytic uraemic syndrome. Eur. J. Clin. Microbiol. Infect. Dis. 13:1074-1076.[CrossRef][Medline]
19 - Thomas, A., T. Cheasty, J. Frost, H. Chart, H. Smith, and B. Rowe. 1996. Verocytotoxin-producing Escherichia coli, particularly serogroup O157, associated with human infections in England and Wales: 1992-1994. Epidemiol. Infect. 117:1-10.[Medline]
20 - Willshaw, G. A., S. M. Scotland, H. R. Smith, and B. Rowe. 1992. Properties of verocytotoxin-producing Escherichia coli of human origin of O-serogroups other than O157. J. Infect. Dis. 166:797-802.[Medline]
21 - Willshaw, G. A., T. Cheasty, H. R. Smith, S. J. O'Brien, and G. K. Adak. 2001. Verocytotoxin-producing Escherichia coli (VTEC) O157 and other VTEC from human infections in England and Wales: 1995 to 1998. J. Med. Microbiol. 50:135-142.[Abstract/Free Full Text]
Journal of Clinical Microbiology, April 2003, p. 1775-1778, Vol. 41, No. 4
0095-1137/03/$08.00+0 DOI: 10.1128/JCM.41.4.1775-1778.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Bardiau, M., Labrozzo, S., Mainil, J. G.
(2009). Putative Adhesins of Enteropathogenic and Enterohemorrhagic Escherichia coli of Serogroup O26 Isolated from Humans and Cattle. J. Clin. Microbiol.
47: 2090-2096
[Abstract]
[Full Text]
-
Tarr, C. L., Nelson, A. M., Beutin, L., Olsen, K. E. P., Whittam, T. S.
(2008). Molecular Characterization Reveals Similar Virulence Gene Content in Unrelated Clonal Groups of Escherichia coli of Serogroup O174 (OX3). J. Bacteriol.
190: 1344-1349
[Abstract]
[Full Text]
-
Gyles, C. L.
(2007). Shiga toxin-producing Escherichia coli: An overview. J ANIM SCI
85: E45-E62
[Abstract]
[Full Text]
-
Hernandes, R. T., Vieira, M. A. M., Carneiro, S. M., Salvador, F. A., Gomes, T. A. T.
(2006). Characterization of Atypical Enteropathogenic Escherichia coli Strains That Express Typical Localized Adherence in HeLa Cells in the Absence of the Bundle-Forming Pilus. J. Clin. Microbiol.
44: 4214-4217
[Abstract]
[Full Text]
-
Torres, A. G., Zhou, X., Kaper, J. B.
(2005). Adherence of Diarrheagenic Escherichia coli Strains to Epithelial Cells. Infect. Immun.
73: 18-29
[Full Text]
-
Shima, K., Terajima, J., Sato, T., Nishimura, K., Tamura, K., Watanabe, H., Takeda, Y., Yamasaki, S.
(2004). Development of a PCR-Restriction Fragment Length Polymorphism Assay for the Epidemiological Analysis of Shiga Toxin-Producing Escherichia coli. J. Clin. Microbiol.
42: 5205-5213
[Abstract]
[Full Text]
-
Mundy, R., Jenkins, C., Yu, J., Smith, H., Frankel, G.
(2004). Distribution of espI among clinical enterohaemorrhagic and enteropathogenic Escherichia coli isolates. J Med Microbiol
53: 1145-1149
[Abstract]
[Full Text]